{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anticancer", "naphthalene", "pyrimidine", "tubulin polymerization inhibitor"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32981901", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "25"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "09", "Day": "26"}], "Language": ["eng"], "ELocationID": ["10.1248/cpb.c20-00575"], "Journal": {"ISSN": "1347-5223", "JournalIssue": {"Volume": "68", "Issue": "12", "PubDate": {"Year": "2020", "Month": "Dec", "Day": "01"}}, "Title": "Chemical & pharmaceutical bulletin", "ISOAbbreviation": "Chem Pharm Bull (Tokyo)"}, "ArticleTitle": "Design, Synthesis and Biological Evaluation of Novel 4-(4-Methoxynaphthalen-1-yl)-5-arylpyrimidin-2-amines as Tubulin Polymerization Inhibitors.", "Pagination": {"StartPage": "1184", "EndPage": "1192", "MedlinePgn": "1184-1192"}, "Abstract": {"AbstractText": ["A novel series of 4-(4-methoxynaphthalen-1-yl)-5-arylpyrimidin-2-amines were designed, synthesized, and evaluated for their anticancer activities. Most of the synthesized compounds exhibited moderate to high antiproliferative activity in comparison to the standard drug cisplatin. Among them, 5i bearing ethoxy at the 4-position of the phenyl was found to be the most active on MCF-7 and HepG2 cancer cell lines, with IC<sub>50</sub> values of 3.77\u2009\u00b1\u20090.36 and 3.83\u2009\u00b1\u20090.26\u2009\u00b5M, respectively. Further mechanism study shown that 5i potently inhibited tubulin polymerization, induced cell cycle arrest at G2/M phase and cell apoptosis in MCF-7 cell line. Furthermore, molecular modeling study suggested that 5i probably binds to the colchicine site of tubulin."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University."}, {"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University."}], "LastName": "Liu", "ForeName": "Wenjing", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University."}], "LastName": "Wang", "ForeName": "Guangcheng", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Food Science and Technology, Shanghai Ocean University."}], "LastName": "Peng", "ForeName": "Zhiyun", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University."}], "LastName": "Li", "ForeName": "Yongjun", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Chem Pharm Bull (Tokyo)", "NlmUniqueID": "0377775", "ISSNLinking": "0009-2363"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amines"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Naphthalenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrimidines"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfonamides"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfones"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin Modulators"}, {"RegistryNumber": "8A1O1M485B", "NameOfSubstance": "Imatinib Mesylate"}, {"RegistryNumber": "K418KG2GET", "NameOfSubstance": "ceritinib"}, {"RegistryNumber": "SML2Y3J35T", "NameOfSubstance": "Colchicine"}, {"RegistryNumber": "Z9K9Y9WMVL", "NameOfSubstance": "macitentan"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Amines"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle Checkpoints"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Colchicine"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Hep G2 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Imatinib Mesylate"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Naphthalenes"}, {"QualifierName": [], "DescriptorName": "Polymerization"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Pyrimidines"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sulfonamides"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sulfones"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tubulin"}, {"QualifierName": ["chemical synthesis", "metabolism"], "DescriptorName": "Tubulin Modulators"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "9", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "28", "Hour": "5", "Minute": "35"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32981901", "10.1248/cpb.c20-00575"]}}]}